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BACKGROUND: Multiple studies have investigated medication errors 
in hospitals in Saudi Arabia; however, prevalence data on prescribing 
errors and associated factors remains uncertain.
OBJECTIVES: Assess the prevalence, type, severity, and factors associ-
ated with prescribing errors.
DESIGN: Retrospective database review.
SETTING: Large tertiary care setting in Riyadh.
PATIENTS AND METHODS: We described and analyzed data related 
to prescribing errors in adults (>14 years of age) from the Medication 
Error Electronic Report Forms database for the two-year period from 
January 2017 to December 2018.  
MAIN OUTCOME MEASURES: The prevalence of prescribing errors 
and associated factors among adult patients.
SAMPLE SIZE: 315 166 prescriptions screened.
RESULTS: Of the total number of inpatient and outpatient prescrip-
tions screened, 4934 prescribing errors were identified for a prevalence 
of 1.56%. The most prevalent types of prescribing errors were improp-
er dose (n=1516; 30.7%) and frequency (n=987; 20.0%). Two-thirds of 
prescribing errors did not cause any harm to patients. Most prescribing 
errors were made by medical residents (n=2577; 52%) followed by spe-
cialists (n=1629; 33%). Prescribing errors were associated with a lack 
of documenting clinical information (adjusted odds ratio: 14.1; 95% CI 
7.7-16.8, P<.001) and prescribing anti-infective medications (adjusted 
odds ratio 2.9; 95% CI 1.3-5.7, P<.01).
CONCLUSION: Inadequate documentation in electronic health re-
cords and prescribing of anti-infective medications were the most com-
mon factors for predicting prescribing errors. Future studies should fo-
cus on testing innovative measures to control these factors and their 
impact on minimizing prescribing errors. 
LIMITATIONS: Polypharmacy was not considered; the data are from a 
single healthcare system.
CONFLICT OF INTEREST: None.
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Medications are fundamental for disease man-agement, but errors in medication usage, which are defined as preventable and un-
intentional drug-induced harm, can be fatal.1 In the 
US, medication-related errors have been estimated to 
cause 140 000- deaths annually and carry a financial 
burden of $76 to $136 billion on healthcare systems.2 
Due to the global threat of medication errors (MEs) on 
healthcare systems, the World Health Organization has 
launched the third Global Patient Safety Challenge with 
the theme of “medication without harm”.3,4 Therefore, 
understanding and preventing MEs are essential for pa-
tient safety across the globe.5 Prescribing errors (PEs) 
are the most preventable types of MEs since they occur 
in the early stages (prescribing/ordering stage);6,7 MEs 
are difficult to resolve after this initial stage.8-12 
Prescribing can be defined as an order written by 
a qualified prescriber intended for testing, diagnosing, 
treating, or preventing diseases.13 Medication prescrip-
tions should include patient information, indication, 
medicine name, formulation, dose, timing, route of ad-
ministration, frequency, and duration of therapy. A PE 
is considered present if any of these items are missing 
or inappropriately written.14-16 PEs can be triggered by 
personal, contextual, and/or knowledge-based factors, 
which include but are not limited to stress, tiredness, 
inadequate attention to detail, lack of competence and 
skills, overloaded schedules, lack of documentation, 
prolonged work hours, and insufficient pharmaceutical 
knowledge and experience.11,17,18
There is conflicting data on the prevalence of PEs 
in Saudi Arabia as the reported prevalence ranges be-
tween 5% and 77%, with many potential factors con-
tributing to inaccuracies, such as hand-written prescrip-
tions, inconsistent setting and study design, lack of an 
electronic reporting system and audits, and the use of 
a wide range of definitions for PEs.8 Furthermore, what 
is known about the factors associated with PEs are not 
thoroughly examined. This study aimed to assess the 
prevalence, type, and severity of PEs that were report-
ed electronically and verified for completeness. At the 
same time, the study also aimed to explore factors as-
sociated with PEs among adult patients at a large ter-
tiary care system in Saudi Arabia.
PATIENTS AND METHODS
This study was a retrospective review of orders in the 
Medication Error Electronic Report Forms (MEERF) da-
tabase reported by healthcare professionals for adult 
(aged >14 years according to the Saudi Ministry of 
Health and King Saud Medical City age classification 
guidelines) inpatient and outpatient prescriptions for 
the period between January 2017 and December 2018 
at a large tertiary care hospital system in Riyadh, Saudi 
Arabia.19,20 The healthcare setting is composed of three 
hospitals with a total bed-capacity of 1269 beds, dental 
and dialysis centers, and five primary healthcare clinics 
at which all inpatient and outpatient prescriptions were 
issued electronically by authorized physicians using the 
computerized physician order entry (CPOE) system. 
The healthcare system policy requires every health-
care professional to complete a MEERF for every ME, 
including PEs. Every MEERF is composed of 18 items 
that fulfill the medication safety criteria of the Institute 
for Safe Medication Practices, the Saudi Central Board 
for Accreditation of Healthcare Institutions, and WHO, 
which is adopted by the Saudi Ministry of Health.4,21,22 
Medication safety officers were responsible for evalu-
ating and analyzing every MEERF for accuracy and 
completeness, presenting ME data quarterly to the 
Pharmacy and Therapeutics Committee, and ensur-
ing preventive measures to avoid reoccurrence. PEs 
were identified and extracted from the MEERF data-
base based on predetermined criteria (Appendix A). 
Ethical approval number (H1RI-16-Jul19-01) was ob-
tained from the institutional review board of King Saud 
Medical City.
Data collection
All MEERFs documented between January 2017 and 
December 2018 were retrieved. Duplicate records 
were removed. PEs were identified and extracted from 
the MEERF database. Data was collected on patient 
gender, age, medications, drug class, route of admin-
istration, and high alert, look-alike and sound-alike 
medications, prescriber category, PE type, severity, lo-
cation, time, and factors associated with or contributed 
to PEs. PE outcomes were classified per the National 
Coordinating Council for Medication Error Reporting 
and Prevention.24 Coded data were exported to an 
Excel sheet for cleaning, management, and validation. 
Medication classification
The Anatomical Therapeutic Chemical (ATC) classifi-
cation system established by the WHO categorizes 
medications according to their effect on body organs 
or their chemical, therapeutic, and pharmacologic 
properties.23 High alert medications pose a high risk of 
causing harm to patients and devastating consequenc-
es when they are used incorrectly (e.g., insulin, potassi-
um chloride injection).23 Look-alike/sound-alike (LASA) 
medications have similar looking or sounding names, 
which increases the potential for errors to occur.
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Statistical analysis 
Categorical variables are presented as frequencies and 
percentages. The chi-squared test was used to test 
the association between the exposure factors and out-
come variables. All factors associated with PEs, with 
a P value <.1 and at least 20 observations in a uni-
variate analysis were included in the multivariate logis-
tic regression model. Data were analyzed using IBM 
SPSS (IBM SPSS Statistics for Windows, Version 25.0. 
Armonk, NY: IBM Corp). Statistical significance was set 
at a P value of <.05.
RESULTS
Of 315 166 prescriptions screened, 9685 MEERFs 
were reported; 6953 for adult patients, out of which 
4934 errors were identified as PEs, with a prevalence 
of 1.56% (4934/315 166) (Figure 1). The 2019 non-PEs 
were used as the other level of the binary multiple lo-
gistic regression. A total of 3358 adult patients were 
identified for 1.5 PEs per patient record; the majority 
were males (53.4%). The mean (SD) age of the study 
cohort was 48.4 (19.3) years. Patients aged 26 to 45 
years (35.9%) and those aged 46 to 65 years (34.9%) 
made up the majority, while older patients represented 
18.8% of the total study cohort.
The most frequently detected PE types were im-
proper dose (n=1516; 30.7%) and frequency (n=987; 
20.0%) (Table 1). Oral and parenteral were the most 
common routes of administration associated with PEs. 
Most were PEs without harm (n=3287; 66.7%); 40 pre-
scriptions were PEs with harm (0.8%). A large num-
ber of PEs were reported as near misses (46.3%). The 
majority of the PEs were issued by medical residents 
(n=2577; 52%), followed by specialists (n=1629; 33%), 
and most occurred in medical wards (n=1970; 39.9%).
Anti-infectives for systemic use, particularly antibac-
terials, were the class most often associated with PEs 
(Table 2), among which cefuroxime was the anti-infec-
tive drug most often associated with PEs (Figure 2). In 
addition, omeprazole and enoxaparin were the most 
frequently reported individual medications associated 
with PEs (Figure 3). The high alert medications (enoxa-
parin, insulin, heparin, potassium chloride, warfarin, 
noradrenaline, and chemotherapy drugs) accounted 
for 18.0% of PEs (n=890), while LASA medications (folic 
acid, insulin, metformin, cholecalciferol, and ceftriax-
one) accounted for 8.5% of PEs (n=420). Most of the 
PEs were reported by pharmacists (92%), followed by 
nurses (5.0%) and physicians (3.0%). 
Multivariate risk factor analysis showed that PEs are 
significantly associated with anti-infective, antineoplas-
tic and immunomodulating agents, systemic hormonal 
preparations excluding sex hormones and insulins, 
alimentary tract and metabolism, cardiovascular sys-
tem, blood and blood-forming organs, and nervous 
system medication classes (Table 3). Moreover, the 
lack of documenting clinical information (age, weight, 
gender, diagnosis, allergy, medication history, etc.) was 
highly associated with PEs (adjusted OR 14.1, 95% CI 
7.7:16.8, P<.01).
DISCUSSION
The prevalence of PEs among adult patients (>14 years 
of age) in a large healthcare system in Riyadh was 1.56 
PEs per 100 prescriptions. PEs accounted for 71% of 
MEERFs. Furthermore, the most significant predictor 
for PEs was a lack of documenting clinical information. 
Among medication classes, prescribing anti-infectives, 
antineoplastic and immunomodulating agents, sys-
temic hormonal preparations, high alert medications, 
and alimentary tract and metabolism medication class-
es were highly associated with PEs. Among individual 
medications, omeprazole, enoxaparin, cefuroxime, and 
atorvastatin were highly associated with PEs. There was 
no significant association between any particular pre-
scribing group and PEs. 
PE prevalence in our study was lower than that re-
ported by national and international studies;4,8,9,25 how-
ever, out of all MEs detected, PE rates were comparable 
to that reported in other studies.26 This inconsistency 
of PE prevalence with other studies suggests the lack 
Figure 1. Selection of medication prescriptions for prescribing errors. 
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Table 1. Characteristics of reported medication 
prescribing errors (n=4934).
Improper dose (over, under or 
extra dose) 1516 (30.7)
Wrong frequency 987 (20.0)
Omission error 400 (8.1)
Wrong drug 353 (7.2)
Wrong strength/concentration 278(5.6)
Drug-drug interaction 216 (4.4)
Wrong duration 188 (3.8)
Wrong route 161 (3.3)
duplication therapy 159 (3.2)
Wrong dosage form 109 (2.2)
Medication without indication 100 (2.1)
Use prohibited abbreviation 90 (1.8)
Wrong documentation entry of 
medications 78 (1.6)
Incomplete information of 
prescription /order 76 (1.5)
Wrong rate of infusion 68 (1.4)
Wrong time of administration 52 (1.2)
Wrong patient 31 (1.1)
Diagnosis was not related to 
medications 28 (1.0)
Contraindicated 24 (0.5)










A) Circumstances or events that 
have the capacity to cause error 1607 (32.6)
PEs with no harm
B) An error occurred, but the error 
did not reach the patient, “Near 
Miss.”
2283 (46.3)
C) An error occurred that reached 
the patient but did not cause 
patient harm
891 (18.1)
D) An error occurred that 
reached the patient and required 
monitoring to confirm that it 




E) An error occurred that may 
have contributed to or resulted 
in temporary harm and required 
intervention
26 (0.5)
F) An error occurred that may 
have contributed to or resulted 
in temporary harm to the patient 
and required initial or prolonged 
hospitalization
12 (0.2)
G) An error occurred that may have 
contributed to permanent harm 0 (0.0)
H) An error occurred that required 




(I) An error occurred that may have 
contributed to a patient’s death 0 (0.0)
Time of PEs occurrence
Day shift 4562 (92.5)
Evening shift 372 (7.5)








Intensive Care Unit 320 (6.5)
Emergency Department 440 (8.9)
Obstetrics & Gynecology 75 (1.5)
Operation Room 57 (1,2)
Oncology 84 (1.7)
Outpatient Clinical 649 (13.2)
Discharge Lounge 5 (0.1)
AKU Center 149 (3.02)
Dental Center 2 (0.04)
Note: The total does not necessarily make 100% due to missing data.
PEs, Prescribing Errors
Table 1 (cont.). Characteristics of reported medication 
prescribing errors (n=4934).
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Table 2. Classes of medications associated with 
prescribing errors using the ATC classification system.




Alimentary tract and metabolism 
drugs 1156 (23.4)
Digestives, incl. Enzymes 2 (0.1)
Drugs for acid related disorders 533 (0.1)
Drugs for constipation 47 (1.0)
Vitamins 165 (3.3)
Mineral supplements 120 (2.4)
Blood and Blood forming organs 
drugs 629 (12.7)
Antianemia preparations 95 (1.9)
Blood substitutes and perfusion 
solutions 32 (0.6)
Antithrombotic agents 498 (10.1)
Antihemorrhagics 3 (0.1)
 Cardiovascular system drugs 871 (17.7)
Agents acting on the renin-
angiotensin system 200 (4.1)
Calcium channel blockers 109 (2.2)
Beta blocking agents 120 (2.4)
Antihypertensives 17 (0.3)
Diuretics 36 (0.7)
Cardiac therapy 65 (1.3)
Lipid modifying agents 324 (6.6)
Dermatological drugs 84 (1.7)
Antifungals for dermatological use 12 (0.2)
Corticosteroids, dermatological 
preparations 64 (1.3)
Antibiotics and chemotherapeutics 
for dermatological use 5 (0.1)
Other dermatological preparations 3 (0.1)
Genitourinary system and sex 
hormones drugs 36 (0.7)
Sex hormones and modulators of 
the genital system 18 (0.4)
Urological 10 (0.2)
Other gynecological 8 (0.2)
Systemic hormonal preparations, 
excluding sex hormones and 
insulin 
53 (1.1)
Thyroid therapy 39 (0.8)




Calcium homeostasis 2 (0.1)
Pituitary and hypothalamic 
hormones and analogs hormones 
and insulins
12 (0.2)
 Anti-infectives for systemic use 1322 (26.8)
Antibacterial for systemic use 1213 (24.6)
Antivirals for systemic use 86 (1.7)
Antimycotics for systemic use 24 (0.5)
Antineoplastic and 
immunomodulating agents 176 (3.6)
Antineoplastic agents 153 (3.1)
Immunosuppressants 23 (0.5)
Musculoskeletal system drugs 171 (3.5)
Anti-inflammatory and 
antirheumatic products 148 (3.0)
Muscle relaxants 4 (0.1)
Drugs for treatment of bone 
diseases 4 (0.1)
Antigout preparations 15 (0.3)






Respiratory system drugs 92 (1.9)
Antihistamines for systemic use 35 (0.7)
Drugs for obstructive airway 
diseases 48 (1.0)
Nasal preparations 2 (0.1)
Cough and cold preparations 7 (0.1)
Antihistamines for systemic use 35 (0.7)
Sensory organs drugs 38 (0.8)
Ophthalmological 38 (0.8)
Various other drugs 33 (0.7)
Diagnostic agents 33 (0.7)
Table 2 (cont.). Classes of medications associated with 
prescribing errors using the ATC classification system.
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of a systematic method for detecting PEs. Despite the 
availability of CPOE and electronic medical informa-
tion databases, these systems appear to be incapable 
of providing accurate and precise detection of MEs 
and PEs. More sophisticated software systems such 
as machine learning and artificial intelligence have 
been shown to be effective in ME and PE detection.27 
On the other hand, poor documentation was signifi-
cantly associated with PEs in our study; nevertheless, 
poor documentation has been minimally addressed in 
the literature.28-30 Inappropriate documentation and 
charting of medical information remains an issue that 
jeopardizes patient safety and continuity of care. It is 
not an internal problem, rather it is a matter of mal-
practice by prescribing physicians and underutiliza-
tion of available resources.31 Evidence has shown that 
Figure 3. The most common medications involved in prescribing errors.
Figure 2. The most common anti-infective medications associated with 
prescribing errors. 
proper documentation ensures the safe transition of 
healthcare, maintains quality assurance, and improves 
patient safety.32,33 One of the suggested solutions to 
improve documentation/charting of medical informa-
tion in electronic health records is the utilization of 
bedside and point-of-care systems such as computers 
on wheels.34
Improper dose and frequency were the most preva-
lent types of PEs; prescribing of anti-infective drugs, 
antibacterial, in particular, was highly associated with 
PEs, out of which cefuroxime (12.9%), meropenem 
(8.1%), while vancomycin (7.1%) stood out as the most 
common antibiotics with PEs. Cefuroxime and vanco-
mycin are considered first-line antibiotics in multiple 
infectious diseases, which unspecialized physicians 
can prescribe in some circumstances, justifying their 
association with PEs. However, meropenem is a re-
served antibiotic that should be prescribed by infec-
tious diseases (ID) physicians when no other options 
are available. This could explain the emergence of an-
timicrobial resistance observed in hospitals and sup-
ports the desperate need to establish antimicrobial 
stewardship programs and recruit infectious disease 
clinical pharmacists.35,36 Omeprazole was the most in-
dividual drug associated with PEs, despite its safety 
profile and controversy over excessive prescription by 
physicians. Reports have shown that the rate of inap-
propriate prescribing of proton pump inhibitors for 
stress ulcer prophylaxis could reach up to 71%, which 
has been attributed to prescribing physician igno-
rance of proper indications and its side effects such as 
Clostridium difficile infections.37,38
Inappropriate documentation of medical informa-
tion is a common problem in hospitals.31 The issue 
compromises patient safety and continuity of care, 
constitutes malpractice by prescribing physicians and 
underuses available resources. Evidence has shown 
that proper documentation ensures the safe transition 
of healthcare, thus maintaining quality assurance and 
improving patient safety.32,33 One of the suggested so-
lutions to improve documentation/charting of medi-
cal information in electronic health records is the uti-
lization of bedside and point-of-care systems such as 
computers on wheels.34
Our study is the largest retrospective study of PEs 
in Saudi Arabia. Limitations include not considering 
the total number of drugs prescribed in each prescrip-
tion as polypharmacy increases the probability of PEs. 
This study is exclusively based on the voluntary report-
ing of MEs, and there is a possibility that other pre-
scribing errors not included could exist. In addition, 
this includes data from a single healthcare setting; 
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Table 3. Multiple logistic regression analysis of factors associated with prescribing errors among patients older than 14 years of age (n=4934).
Characteristics Prescribing errors  (n=4934)
Medication errors  
other than prescribing 
errors  (n=2019)
P value Odds ratio (OR) (95% CI)
Adjusted OR 
(95% CI)
Mean (SD) age (years) 48.4 (19.23) 49.9 (18.79) .04 1.3 (1.1-1.3) 0.9 (0.7-1.1)
Gender
   Male 2736 1170 <.01 1.3 (1.1-1.6) 1.0  (0.9-1.3)
   Female 2198 849
Time
   Day shift (0700-1900) 4562 1480 <.01 4.5 (3.9-5.2) 1.1 (0.9-1.9)
Route of administration
   Oral 2876 821 <.01 2.0 (1.8-2.3) 0.4 (0.5-1.7)
   Injectable 1897 1100 <.01 0.5 (0.5 -0 .6) 0.5 (0.5-0.6)
   Inhalation 56 43 .01 0.5 (0.4-.8) 0.5 (0.4-0.8)
   Topical 60 33 <.01 0.5 (0.2-2.3) 0.5 (0.2-2.3)
   Other (reference level) 45 22 <.01
Medication class
   Anti-infective for systemic 
   use 1322 815 <.01 1.8 (1.1-2.4) 2.9 (1.3-5.7)
    Alimentary tract and 
   metabolism   1156 289 <.01 2.7 (1.9-3.5) 2.2 (1.8-2.7)
   Cardiovascular system 871 287 <.01 2.2 (1.6-3.1) 1.9 (1.6-2.3)
   Blood and blood forming  
   organs  629 201 <.01 1.7 (1.2-2.4) 1.6 (1.3-1.9)
   Nervous system 273 153 <.01 2.4 (1.9-4.8) 1.5 (1.3-1.9)
   Antineoplastic and 
   immunomodulating agents  176 31 <.01 2.9 (1.6-5.2) 2.6 (1.6-4.3)
   Musculoskeletal system 171 35 <.01 0.9 (0.7-1.4) 0.8 (0.6-1.3)
   Respiratory system 92 56 .02 0.8 (0.3-1.9) 0.7 (0.2-1.9)
   Dermatological 84 34 .96
   Systemic hormonal 
   preparations excluding sex 
   hormones and insulins
53 30 .02 2.8 (1.3-5.7) 2.3 (1.2-4.7)
   Sensory organs 38 11 .31
   Genitourinary system and 
   sex hormones 36 6 .04 0.9 (0.8-1.9) 0.8 (0.3-1.5)
   Various (reference level) 33 71 <.01
Prescriber made error <.01
   Consultant 572 59 <.01 0.9 (0.1 -1.0) 0.3 (0.2-0.4)
   Specialist 1629 117 <.01 0.9 (0.1-1.0) 1.0 (0.1-2.0)
   Resident 2577 202 <.01 1.0 (0.23-1.1) 1.0 (0.1-2.0)
   Others (reference level) 156 179 .01
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Characteristics Prescribing errors  (n=4934)
Medication errors  
other than prescribing 
errors  (n=2019)




   Yes 890 239 <.01 1.7 (1.4-2.2) 2.3 (1.5-3.2)
Look-a-like and sound-alike 
medication <.01
   Yes 420 244 <.01 1.8 (1.5-2.3) 1.8 (1.4-2.3)
Other causesa <.01
   Lack of documenting clinical 
   information 1279 83 <.01 14.1 (8.3-16.7) 14.1 (7.7-16.8)
   Drug information missing 1441 1601 <.01 1.3 (0.9-1.7) 1.0 (0.7-1.4)
   Miscommunication of drug 
   order 749 166 <.01 0.9 (0.5-1.1) 0.6 (0.4-1.1)
   Physicians schedule overload 485 141 <.01 0.9 (0.7-1.4) 0.8 (0.2-1.2)
   Physicians outdated 
   medication information 1684 310 <.01 1.6 (1.3-1.7) 1.6 (1.4-1.7)
   Improper medical history 
   retrieval 53 16 .04 1.5 (1.3-1.6) 1.3 (1.2-1.8)
   Improper order verification 221 115 .03 0.9 (0.2-1.3) 0.4 (0.2-1.1)
   Inconsistent supply of 
   medications (reference level) 746 929 <.01
Bolded values included in multiple logistic regression model. aCauses listed on the Medication Error Electronic Report Forms.
Table 3 (cont.). Multiple logistic regression analysis of factors associated with prescribing errors among patients older than 14 years of age 
(n=4934).
however, such a system unifies the method of detec-
tion, reporting, and definition of PEs. In conclusion, 
inadequate documentation in electronic health records 
and prescribing of anti-infectives were the most com-
mon predicting factors for PEs. Future studies should 
focus on testing innovative measures to control these 
factors and their impact on minimizing PEs.
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